131 related articles for article (PubMed ID: 1916118)
1. [Anomalies of fundic argyrophil cell proliferation (enterochromaffin-like cells) in Zollinger-Ellison syndrome].
Cadiot G; Lehy T; Ruszniewski P; Sobhani I; Vallot T; Mignon M
Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):41C-46C. PubMed ID: 1916118
[No Abstract] [Full Text] [Related]
2. [From acid secretion inhibition to enterochromaffin-like cell proliferation. Traps on the path].
Bonfils SJ
Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):59C-64C. PubMed ID: 1916120
[No Abstract] [Full Text] [Related]
3. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
Feurle GE
Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
[TBL] [Abstract][Full Text] [Related]
4. [Endocrine cell proliferation of the fundic mucosa in men not associated with hypergastrinemic states].
Bordi C; D'Adda T; Azzoni C; Pilato FP
Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):51C-58C. PubMed ID: 1680768
[No Abstract] [Full Text] [Related]
5. Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.
Hirschowitz BI; Worthington J; Mohnen J; Haber M
Aliment Pharmacol Ther; 2007 Sep; 26(6):869-78. PubMed ID: 17767471
[TBL] [Abstract][Full Text] [Related]
6. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.
Maton PN; Lack EE; Collen MJ; Cornelius MJ; David E; Gardner JD; Jensen RT
Gastroenterology; 1990 Oct; 99(4):943-50. PubMed ID: 1697548
[TBL] [Abstract][Full Text] [Related]
7. Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G-cell hyperfunction.
Annibale B; Delle Fave G; Azzoni C; Corleto V; Camboni G; D'Ambra G; Pilato FP; Bordi C
Aliment Pharmacol Ther; 1994 Feb; 8(1):95-104. PubMed ID: 7910489
[TBL] [Abstract][Full Text] [Related]
8. Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome.
Cadiot G; Vissuzaine C; Potet F; Mignon M
Dig Dis Sci; 1995 Jun; 40(6):1275-8. PubMed ID: 7781446
[TBL] [Abstract][Full Text] [Related]
9. Gastric carcinoid tumours in patients with Zollinger-Ellison syndrome on long-term omeprazole.
Goldfain D; le Bodic MF; Lavergne A; Galian A; Modigliani R
Lancet; 1989 Apr; 1(8641):776-7. PubMed ID: 2564577
[No Abstract] [Full Text] [Related]
10. Gastric endocrine cell proliferation and fundic argyrophil carcinoid tumors in patients with the Zollinger-Ellison syndrome.
Cadiot G; Lehy T; Mignon M
Acta Oncol; 1993; 32(2):135-40. PubMed ID: 8323754
[TBL] [Abstract][Full Text] [Related]
11. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.
Solcia E; Capella C; Fiocca R; Rindi G; Rosai J
Am J Surg Pathol; 1990 Jun; 14(6):503-13. PubMed ID: 1970928
[TBL] [Abstract][Full Text] [Related]
12. Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment.
Cadiot G; Lehy T; Ruszniewski P; Bonfils S; Mignon M
Dig Dis Sci; 1993 Jul; 38(7):1307-17. PubMed ID: 8100759
[TBL] [Abstract][Full Text] [Related]
13. Gastric carcinoid tumors associated with chronic hypergastrinemia in a patient with Zollinger-Ellison syndrome.
Berger MW; Stephens DH
Radiology; 1996 Nov; 201(2):371-3. PubMed ID: 8888225
[TBL] [Abstract][Full Text] [Related]
14. Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome?
Cadiot G; Laurent-Puig P; Thuille B; Lehy T; Mignon M; Olschwang S
Gastroenterology; 1993 Aug; 105(2):579-82. PubMed ID: 8101501
[TBL] [Abstract][Full Text] [Related]
15. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
16. Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome.
Aprile MR; Azzoni C; Gibril F; Jensen RT; Bordi C
Hum Pathol; 2000 Feb; 31(2):140-8. PubMed ID: 10685627
[TBL] [Abstract][Full Text] [Related]
17. Gastrin cell distribution in normal human stomachs and in patients with Zollinger-Ellison syndrome.
Voillemot N; Potet F; Mary JY; Lewin MJ
Gastroenterology; 1978 Jul; 75(1):61-5. PubMed ID: 401402
[TBL] [Abstract][Full Text] [Related]
18. [Antisecretory drugs, hypergastrinemia and hyperplasia of enterochromaffin-like cells (ECL)].
Andriulli A; Mangia A; Lawson F
Minerva Gastroenterol Dietol; 1991; 37(3):135-40. PubMed ID: 1686409
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole treatment of severe peptic disease associated with antral G cell hyperfunction and hyperpepsinogenemia I in an infant.
De Giacomo C; Fiocca R; Villani L; Licardi G; Scotta MS; Solcia E
J Pediatr; 1990 Dec; 117(6):989-93. PubMed ID: 2246706
[No Abstract] [Full Text] [Related]
20. Diagnosis and treatment of ECL cell tumors.
Cadiot G; Cattan D; Mignon M
Yale J Biol Med; 1998; 71(3-4):311-23. PubMed ID: 10461362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
